Company / PP&E (Net)
Globus Medical PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$564.5M
FY2025
5-year range
$221.1M / $586.9M
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
#44 of 130
Health Care
What the data says
At $564M, Globus Medical's pp&e (net) ranks #44 of 130 in the Health Care sector. Declined from $587M to $564M over the past 2 years.
Based on SEC 10-K filings.
$564M in FY2025 with a 5-year CAGR of +21.1%.
Declined from $587M to $564M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +32.3%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Sector benchmark
#44 of 130 in Health CareTop 34% of 130This company $564.5M Sector average $1.3B
▼
-58.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.1%, indicating consistent growth.
- In FY2025, pp&e (net) increased 0.5% year-over-year.
- Ranks #44 out of 130 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $564.5M | +0.5% |
| FY2024 | $561.9M | -4.3% |
| FY2023 | $586.9M | +140.8% |
| FY2022 | $243.7M | +10.2% |
| FY2021 | $221.1M | +1.9% |
| FY2020 | $216.9M | +8.5% |
| FY2019 | $199.8M | +16.3% |
| FY2018 | $171.9M | +20.1% |
| FY2017 | $143.2M | +15.2% |
| FY2016 | $124.2M | +8.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026